A trial fibrillation (AF) is the most common cardiac arrhythmia and is associated with both cardiovascular and cerebrovascular morbidity and mortality. According to a population-based study, it is estimated that >2 million US adults have been diagnosed with AF, and by 2050, this number is expected to increase to 5.6 million. 1 Given the high prevalence of AF, finding methods to identify individuals at risk for AF development is of great value in both clinical-and population-based studies.
for analyzing LA function. However, given the anatomic location of the LA, the thin atrial wall and the presence of pulmonary veins and LA appendage, assessment of LA function can be challenging. 3 On the contrary, cardiac magnetic resonance (CMR) imaging is a well-established method for the assessment of cardiac deformation given its excellent ability to define endocardial and epicardial borders. Therefore, CMR has been proposed as the reference method to measure atrial and ventricular volumes. 17 In this study, we sought to examine the association of LA size and function measured with feature-tracking CMR and incident AF in a large asymptomatic multiethnic population. We hypothesized that reduced left atrial (LA) function, assessed as decreased LA emptying fractions (LAEFs) and longitudinal LA strain, is associated with incidence of AF.
Methods

Study Design
The present study was designed as a case-cohort study within MESA (Multi-Ethnic Study of Atherosclerosis). MESA protocol has previously been described in detail. 18 Briefly, between July 2000 and August 2002, 6814 individuals were recruited from 6 US communities in North Carolina, New York, Maryland, Illinois, Minnesota, and California. The participants were aged between 45 and 84 years from 4 different self-reported racial/ethnic backgrounds (white, black, Hispanic, and Chinese). All participants were free of any clinically apparent cardiovascular disease. The study protocol was approved by the institutional review board of each study site.
Follow-Up
Approximately every 9 months, each participant was contacted by a telephone interviewer to inquire about hospital admissions, cardiovascular outpatient diagnoses, and deaths. Medical records and information were successfully obtained on 98% of reported hospitalized cardiovascular events and 95% of reported outpatient cardiovascular diagnostic encounters.
Identification of AF Cases
Incident cases of AF during follow-up were identified through MESA event surveillance and, for participants enrolled in fee-for-service Medicare, from inpatient Medicare claims data. As a part of standard event surveillance procedures in the MESA cohort, all hospitalizations are identified during follow-up calls to study participants or a proxy. Discharge diagnostic and procedure codes from those hospitalizations are abstracted. AF was considered to be present if an International Classification of Diseases, Ninth Revision diagnosis code 427.31 or 427.32 was present. AF hospitalizations associated with open cardiac surgery were excluded. If the first AF claim occurred before the baseline MESA examination, the participant was considered to have prevalent AF and thus was excluded from the analysis.
Covariates
Standardized questionnaires were used at baseline to collect information about age, sex, racial/ethnic background, cigarette smoking; medication inventory was used to collect information on prescription and nonprescription medications. Cigarette smoking was categorized as current, former, or never. Body mass index was calculated as weight divided by height squared (kg/m 2 ) with weight measured to the nearest 0.5 kg and height to the nearest 0.1 cm. Blood pressure was measured 3× using a Dinamap model Pro 100 automated oscillometric sphygmomanometer (Critikon; Tampa, FL) while the participants were resting in a seated position. The average of the last 2 measurements was used in the analysis. Fasting blood glucose, total, and high-density lipoprotein cholesterol levels were measured after fasting for 12 hours. Fasting glucose was obtained by a thin-film adaptation of the glucose oxidase method (Johnson & Johnson Clinical Diagnostics, Inc, Rochester, NY). Diabetes mellitus was defined as a fasting glucose of ≥126 mg/dL or use of hypoglycemic medication. N-terminal pro-brain-natriuretic peptide (NT-proBNP) was analyzed centrally at the core laboratory (University of Vermont, Burlington).
Image Analysis
Baseline MR images were acquired using 1.5T MR scanners: Signa LX or CVi (GE Medical Systems, Waukesha, WI) or Symphony or Sonata (Siemens Medical Systems, Erlangen, Germany). Long-axis cine images were obtained from 2-chamber and 4-chamber views, using ECG-gated fast gradient-echo pulse sequence. All cine images were acquired with a temporal resolution of ≈50 ms. A stack of short-axis images recorded at end diastole was obtained for the LV mass assessment. The detailed MR protocol has previously been described. 19 Multimodality Tissue Tracking software (MTT, version 5.0, Toshiba, Japan) was used to quantify LA strain and volume from baseline 4-and 2-chamber cine CMR images. 20 This method has been previously validated with great reproducibility (intraclass correlation coefficients between 0.90 and 0.97 for LA volumes and strain). 20, 21 A single experienced operator blinded to the case status of the participant defined endocardial and epicardial borders of the LA at end systole. Using the marked points, the software creates endocardial and epicardial borders and then tracks LA tissue in subsequent frames (Movie I in the Data Supplement). The endocardial and epicardial contours generated by the software are then followed by the operator during the cardiac cycle for quality control. Maximum, minimum, and preatrial contraction LA volumes were extracted from volume curves that were created using the area-length method from apical 4-and 2-chamber views, volume=(0.848×area 4ch ×area 2ch )/([length 2ch +length 4ch ]/2). 22 An example of LA volume cure in a cardiac cycle is shown in Figure 1 Using the measured LA volumes at different points of cardiac cycle, LA function was calculated as follows:
Strain Measurement
The software calculates global longitudinal atrial strain by averaging longitudinal strain of all LA segments in 2-and 4-chamber views during each cardiac cycle. Global peak longitudinal LA strain (peak LA strain) was measured from the global longitudinal strain curve ( Figure 1 ).
Statistical Analysis
Continuous variables are presented as mean±SD. Categorical variables are presented as frequencies and percentages. Differences between group means were evaluated with t tests for continuous variables or χ 2 analysis for categorical variables. Logarithmic transformation was applied to NT-proBNP before entry into the models because of its skewed distribution. We used modified Cox proportional hazard models weighted for the stratified case-cohort sampling design to estimate the hazard ratios of developing AF as a function of measured LA variables in 3 models. 23 Cox models were adjusted for significant predictors of AF from a backward selection among the following variables: age, sex, race/ethnicity, body mass index, cigarette smoking, systolic and diastolic blood pressures, hypertensive medication use, diabetes mellitus, and left ventricular ejection fraction in model 1. We additionally adjusted for left ventricular mass and ln NT-proBNP in model 2. To avoid colinearity, correlations between continuous variables were tested using the Spearman correlation coefficient and variables with r>0.50 were not included in the same multivariable model. All statistical analyses were performed using Stata software (version 11.2; Stata Corp, TX).
Results
The flowchart of the study is illustrated in Figure 2 . Of 5004 participants with baseline MRI, 37 were excluded because of the diagnosis of AF before enrolling into MESA. The subcohort consisted of 400 participants who were randomly selected from the MESA cohort irrespective of their case status. The cases were 214 participants who developed AF over a median follow-up of 7.6 years. It was feasible to measure LA variables in 197 cases of AF and 304 noncases.
The analysis included 322 participants in the subcohort and 197 participants who developed AF; 18 participants were included in this analysis as both AF cases and members of the subcohort. The subcohort and MESA cohort were similar in demographics, baseline characteristics, and incidence of cardiovascular events ( Table I in the Data Supplement). The baseline characteristics of participants who developed AF and the subcohort are summarized in Table 1 . Participants with incident AF were older (70 versus 61 years) and were more likely to be men (62% versus 48%) compared with the subcohort. Higher systolic blood pressure, hypertension diagnosis, and being on hypertension medications were all more common in AF cases than in the subcohort. Although the LV ejection fraction was similar in the 2 groups, AF cases had a higher LV mass and NT-proBNP.
LA Structure and Function
The LA volume was 17% larger at baseline in patients with incident AF compared with subcohort participants (LAVI max , 41±15 versus 35±10 mL/m 2 ; P<0.001 and LAVI min , 26±11 versus 20±7 mL/m 2 ; P<0.001; Table 2 ). In parallel, peak LA strain and all LAEFs (passive, active, and total) were lower in AF cases (P<0.001 for all).
Association of LA Function and Incident AF
Association of LA structural and functional variables with incident AF, analyzed with multivariable Cox regression models, have been summarized in Table 3 . Because of high correlation between LAVI max and LAVI min (r=0.92), only LAVI max was included in the multivariable models. In model 1 after adjustment for age, sex, ethnicity, hypertensive medications, and systolic blood pressure, all LA variables were significantly associated with incident AF. In model 2 after additionally adjusting for ln NT-proBNP and LV mass, the association remained significant for all variables except for active LAEF. Larger LA was positively associated with incident AF (HR for LAVI max , 1.38 per SD; P=0.042). Decreased LA function assessed as decreased passive and total emptying fractions, and peak LA strain was also associated with incident AF (HRs per SD for passive LAEF, 0.55; P<0.001; for total LAEF, 0.70; P=0.020; and for peak LA strain, 0.68; P=0.031).
Discussion
In this case-cohort study, reduced LA function measured by CMR feature tracking was associated with incident AF. Parallel to enlarged LA size, passive and total LAEF and also peak LA strain were lower at baseline in participants who developed AF. This association was independent of traditional cardiovascular risk factors, LV mass, and NT-proBNP. To the best of our knowledge, this is the first study using feature-tracking CMR to assess this association in a large multiethnic cohort. 
Left Atrial Function and Incident Atrial Fibrillation
Structural and functional changes in LA are present before AF development. Therefore, early detection of these changes in individuals at higher risk for AF has a great clinical impact. As both animal and human studies have shown, LA remodeling, especially in the earlier stages, could be reversible after using certain medications. [24] [25] [26] Although multiple imaging modalities have been proposed to measure LA volume and assess LA function, given the far field location of LA and the thin asymmetrical wall, the assessment of its function is challenging. In this study, we used CMR feature tracking to measure phasic changes in the volume and assess phasic function of the LA.
LA Size and Incident AF
In the absence of valvular disease or AF, LA volume has been shown to reflect the burden of cardiovascular disease. 27, 28 Based on multiple studies performed with echocardiography, enlarged LA is a well-known risk factor for AF development. [12] [13] [14] 29 According to a study on 1924 subjects in the Framingham Heart Study, every 5-mm increase in LA diameter measured with M-mode echocardiography was associated with 42% increase in the risk of AF. 13 Later studies using 2D echocardiography were able to examine this association with LA volume. Based on a study performed by Tsang et al 29 on 317 participants, LAVI was a stronger marker of cardiovascular events including AF compared with LA diameter and area. In another study of 574 adults, both LAV min and LAV max measured with 2D echocardiography were independently associated with AF/flutter development. 14 The findings of our study, which has been performed using feature-tracking MRI, are in agreement with previous studies using echocardiography. In our study, increased LA volume was significantly associated with incident AF.
LA Function and Incident AF
LA modulates left ventricular filling and function in 3 distinct phases. It functions as a reservoir for pulmonary venous return during ventricular systole, as a conduit for pulmonary venous return during early ventricular diastole, and as a booster pump that augments ventricular filling at the end of ventricular diastole. In patients with AF, not only the booster pump function is absent but also reservoir and conduit functions are decreased. Studies suggest that these functional changes precede development of AF; therefore, assessment of LA function in a population at risk of AF is of great interest. Traditionally, Doppler imaging has been used to assess the LA wall motion. In a study of 942 participants in the Framingham study, decreased transmitral Doppler was associated with new onset AF independent of LA size, suggesting impaired LA booster pump function preceding AF development. 15 Phasic LA function can be also assessed using volumetric and strain analysis methods. In volumetric method, total, passive, and active LAEF are surrogates of reservoir, conduit, and booster pump functions, respectively. Peak LA longitudinal strain is also used as a representative of LA reservoir function. 30 In a study performed by Abhayaratna et al, 16 total LAEF measured with 2D echocardiography was associated with new onset AF/flutter in 574 adults >65 years of age who were referred for clinically indicated echocardiography. In a recent study with speckle-tracking echocardiography on 580 adults with 32 patients with new onset AF, out of phasic LA function, strain and strain rate measurements, only active LAEF was independently associated with incident AF. 31 In this study, a cutoff of active LAEF ≤20% had a sensitivity and specificity of 88% and 81%, respectively, for new onset AF. In our study, similar to the study by Hirose et al, 31 active LAEF was significantly associated with incident AF after adjusting for significant predictors of AF (model 1). However, after adjusting for NT-proBNP and LV mass, the association became nonsignificant. We further explored the association of NT-proBNP and emptying fractions and found that active LAEF but not passive LAEF is inversely associated with NT-proBNP (r=−0.19; P=0.027). To our knowledge, there are no other studies comparing the association of passive and active LAEF with incident AF in general population. Although in a study on 1120 patients with AF, increased AF burden was associated with lower passive and total LAEF but not active LAEF. Previously, we also found that in patients with AF undergoing catheter ablation, CMR measured passive LAEF but not active LAEF is associated with increased LA late gadolinium enhancement. 4 These findings may suggest that passive LAEF is a more sensitive and independent marker of LA remodeling in patients with AF or at risk of having AF. In our study, peak LA strain, total and passive LAEF, as measures of LA reservoir, global, and conduit phase functions, respectively, were independently associated with new onset AF.
LA remodeling, especially in early stages, can be reversible. Many studies have shown that certain medications such as angiotensin-converting enzyme inhibitors 26 or angiotensin II receptor antagonists 32 are associated with improvement of LA function and reduction of new onset AF in individuals at risk of AF. 33 In addition, based on animal studies, aldosterone antagonists such as spironolactone have been shown to reduce LA dilation and fibrosis in rats with heart failure after myocardial infarction. 34 LA remodeling is present and detectable using noninvasive methods such as feature-tracking CMR before development of AF. Inclusion of LA functional variables together with other known risk factors of AF may help to create stronger predictive models to identify population at risk of AF and therefore to initiate earlier targeted intervention. This approach could be tested in future trials based on LA variables used in this study.
Strengths and Limitations
To our knowledge, our study is among the first studies to investigate the association of LA function and new onset AF using CMR imaging. Other strengths are the wide age range of the study population, in contrast to most other studies on LA function, and also the availability of comprehensive clinical and imaging data and biomarkers. We also acknowledge a few study limitations. Considering the fact that images were acquired using Gradient Echo Sequences, the CMR images were not interpretable in 15% of the study population. However, this rate is about the same or lower than the other studies using speckle-tracking echocardiography in measurements of LA function. 35, 36 We used area-length method to measure LA volumes. Therefore, the calculated volumes might be an underestimation of the true volumes by 11.5% to 20% depending on the alignment of the acquired slice with true orientation of LA. 22, 37 However, this method is widely used in clinical and research studies. 38 Incident AF was identified based on hospital discharge codes, which may not be accurate and also may underestimate AF diagnosis as many of AF cases are asymptomatic and do not require hospitalization. However, a validation substudy on 45 MESA participants with the diagnosis of AF based on hospital discharge codes confirms the diagnosis of AF in 93% of hospitalizations. 39 In addition, based on a systematic review using information from 16 unique studies, a large proportion of prevalent AF cases identified by International Classification of Diseases, Ninth Revision code were valid (positive predictive value, 70%-96%; median, 89%). 40 
Conclusions
In this multiethnic study population free of clinical cardiovascular disease, elevated LA volume and decreased LA reservoir and conduit functions measured with feature-tracking CMR imaging were associated with incident AF. This association is suggestive of alterations of LA function before the AF development. Moreover, CMR feature-tracking was feasible to analyze phasic LA function. Assessment of LA function in addition to LA volume may add further information in detecting individuals at higher risk of AF development.
